COMT and Miyoshi myopathy: In light of a meta-analysis published in PLOS ONE, the interaction between COMT Val158Met and cannabis is not sufficiently documented, which tempers previous hypotheses and suggests that COMT testing should not be routinely used for risk stratification in MM [11].